The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Delays and Disruptions in Cancer Health Care Due to COVID-19 Pandemic: Systematic Review
Open accessAbstract
PURPOSE: There has been noteworthy concern about the impact of COVID-19 pandemic on health services including the management of cancer. In addition to being considered at higher risk for worse outcomes from COVID-19, people with cancer may also experience disruptions or delays in health services. This systematic review aimed to identify the delays and disruptions to cancer services globally. METHODS: This is a systematic review with a comprehensive search including specific and general databases. We considered any observational longitudinal and cross-sectional study design. The selection, data extraction, and methodological assessment were performed by two independent reviewers. The methodological quality of the studies was assessed by specific tools. The delays and disruptions identified were categorized, and their frequency was presented. RESULTS: Among the 62 studies identified, none exhibited high methodological quality. The most frequent determinants for disruptions were provider- or system-related, mainly because of the reduction in service availability. The studies identified 38 different categories of delays and disruptions with impact on treatment, diagnosis, or general health service. Delays or disruptions most investigated included reduction in routine activity of cancer services and number of cancer surgeries; delay in radiotherapy; and delay, reschedule, or cancellation of outpatient visits. Interruptions and disruptions largely affected facilities (up to 77.5%), supply chain (up to 79%), and personnel availability (up to 60%). CONCLUSION: The remarkable frequency of delays and disruptions in health care mostly related to the reduction of the COVID-19 burden unintentionally posed a major risk on cancer care worldwide. Strategies can be proposed not only to mitigate the main delays and disruptions but also to standardize their measurement and reporting. As a high number of publications continuously are being published, it is critical to harmonize the upcoming reports and constantly update this review.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Rayyan-a web and mobile app for systematic reviews.
Ouzzani, M., Hammady, H., Fedorowicz, Z., & Elmagarmid, A. (2016) · Systematic Reviews · doi:10.1186/s13643-016-0384-4 · Cited by 26,092
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Sterne, J. A., Hernán, M. A., Reeves, B. C., Savović, J., Berkman, N. D., Viswanathan, M., Henry, D., Altman, D. G., Ansari, M. T., Boutron, I., et al. (2016) · BMJ · doi:10.1136/bmj.i4919 · Cited by 20,329
Cochrane Handbook for Systematic Reviews of Interventions
(2019) · doi:10.1002/9781119536604 · Cited by 14,828
SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China
Yu, J., Ouyang, W., Chua, M. L. K., & Xie, C. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.0980 · Cited by 1,071
Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands
Dinmohamed, A. G., Visser, O., Verhoeven, R. H. A., Louwman, M. W. J., van Nederveen, F. H., Willems, S. M., Merkx, M. A. W., Lemmens, V. E. P. P., Nagtegaal, I. D., & Siesling, S. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30265-5 · Cited by 699
Lai, A. G., Pasea, L., Banerjee, A., Hall, G., Denaxas, S., Chang, W. H., Katsoulis, M., Williams, B., Pillay, D., Noursadeghi, M., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-043828 · Cited by 447
Waterhouse, D. M., Harvey, R. D., Hurley, P., Levit, L. A., Kim, E. S., Klepin, H. D., Mileham, K. F., Nowakowski, G., Schenkel, C., Davis, C., et al. (2020) · JCO Oncology Practice · doi:10.1200/op.20.00275 · Cited by 199
A Global Survey on the Impact of COVID-19 on Urological Services
Teoh, J. Y.-C., Ong, W. L. K., Gonzalez-Padilla, D., Castellani, D., Dubin, J. M., Esperto, F., Campi, R., Gudaru, K., Talwar, R., Okhunov, Z., et al. (2020) · European Urology · doi:10.1016/j.eururo.2020.05.025 · Cited by 173
Breast Cancer and COVID-19: The Effect of Fear on Patients' Decision-making Process
VANNI, G., MATERAZZO, M., PELLICCIARO, M., INGALLINELLA, S., RHO, M., SANTORI, F., COTESTA, M., CASPI, J., MAKAROVA, A., PISTOLESE, C. A., et al. (2020) · In Vivo · doi:10.21873/invivo.11957 · Cited by 166
Juanjuan, L., Santa-Maria, C. A., Hongfang, F., Lingcheng, W., Pengcheng, Z., Yuanbing, X., Yuyan, T., Zhongchun, L., Bo, D., Meng, L., et al. (2020) · Clinical Breast Cancer · doi:10.1016/j.clbc.2020.06.003 · Cited by 124
Impact of the coronavirus disease 2019 pandemic on the quality of life for women with ovarian cancer
Frey, M. K., Ellis, A. E., Zeligs, K., Chapman‐Davis, E., Thomas, C., Christos, P. J., Kolev, V., Prasad-Hayes, M., Cohen, S., Holcomb, K., et al. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.06.049 · Cited by 120
The impact of COVID-19 pandemic in the colorectal cancer prevention
Blanco, G. D. V., Calabrese, E., Biancone, L., Monteleone, G., & Paoluzi, O. A. (2020) · International Journal of Colorectal Disease · doi:10.1007/s00384-020-03635-6 · Cited by 116
Early impact of the COVID-19 pandemic on paediatric cancer care in Latin America
Vásquez, L., Sampor, C., Villanueva, G. A., Maradiegue, E., Lombardi, M. G., Garcia, W. C. G., Moreno, F., Díaz, R., Cappellano, A. M., Portilla, C., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30280-1 · Cited by 103
Ferrari, A., Zecca, M., Rizzari, C., Porta, F., Provenzi, M., Marinoni, M., Schumacher, R. F., Luksch, R., Terenziani, M., Casanova, M., et al. (2020) · Pediatric Blood & Cancer · doi:10.1002/pbc.28410 · Cited by 97
Gasparri, M. L., Gentilini, O., Lüftner, D., Kuehn, T., Kaidar‐Person, O., & Poortmans, P. M. (2020) · The Breast · doi:10.1016/j.breast.2020.05.006 · Cited by 90
Delayed cancer diagnoses and high mortality in children during the COVID‐19 pandemic
Ding, Y., Ramakrishna, S., Long, A. H., Phillips, C., Montiel-Esparza, R., Diorio, C. J., Bailey, L. C., Maude, S. L., Aplenc, R., Batra, V., et al. (2020) · Pediatric Blood & Cancer · doi:10.1002/pbc.28427 · Cited by 87
Teleurology in the Time of Covid-19 Pandemic: Here to Stay?
LUCIANI, L. G., Mattevi, D., Cai, T., Giusti, G., Proietti, S., & MALOSSINI, G. (2020) · Urology · doi:10.1016/j.urology.2020.04.004 · Cited by 76
Healthcare utilization among breast cancer patients during the COVID-19 outbreak
Shinan‐Altman, S., Levkovich, I., & Tavori, G. (2020) · Palliative & Supportive Care · doi:10.1017/s1478951520000516 · Cited by 75
Reduction in skin cancer diagnosis, and overall cancer referrals, during the COVID‐19 pandemic
Earnshaw, C. H., Hunter, H. J. A., McMullen, E., Griffiths, C. E. M., & Warren, R. B. (2020) · British Journal of Dermatology · doi:10.1111/bjd.19267 · Cited by 73
Gebbia, V., Piazza, D., Valerio, M. R., Borsellino, N., & Firenze, A. (2020) · JCO Global Oncology · doi:10.1200/go.20.00118 · Cited by 68
Global Survey on Pancreatic Surgery During the COVID-19 Pandemic
Oba, A., Stoop, T. F., Löhr, M. J., Hackert, T., Zyromski, N. J., Nealon, W. H., Unno, M., Schulick, R. D., Al-Musawi, M. H., Wu, W., et al. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000004006 · Cited by 62
Jereczek‐Fossa, B. A., Pepa, M., Marvaso, G., Bruni, A., Buglione, M., Catalano, G., Filippi, A. R., Franco, P., Gambacorta, M. A., Genovesi, D., et al. (2020) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2020.04.061 · Cited by 54
Büntzel, J., Klein, M., Keinki, C., Walter, S., Büntzel, J., & Hübner, J. (2020) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-020-03249-z · Cited by 52
Changes in head and neck oncologic practice during the COVID ‐19 pandemic
Brody, R. M., Albergotti, W. G., Shimunov, D., Nicolli, E. A., Patel, U. A., Harris, B. N., & Bur, A. M. (2020) · Head & Neck · doi:10.1002/hed.26233 · Cited by 46
Gill, S., Hao, D., Hirte, H. W., Campbell, A., & Colwell, B. (2020) · Current Oncology · doi:10.3747/co.27.6643 · Cited by 46
Cancer patients affected by COVID-19: Experience from Milan, Lombardy
Bogani, G., Ditto, A., Bosio, S., Brusadelli, C., & Raspagliesi, F. (2020) · Gynecologic Oncology · doi:10.1016/j.ygyno.2020.06.161 · Cited by 44
Poggio, F. B., Tagliamento, M., Maïo, M. D., Martelli, V., Maria, A. D., Barisione, E., Grosso, M., Boccardo, F., Pronzato, P., Mastro, L. D., et al. (2020) · JCO Oncology Practice · doi:10.1200/op.20.00297 · Cited by 44
Balakrishnan, A., Lesurtel, M., Siriwardena, A. K., Heinrich, S., Serrablo, A., Besselink, M. G., Erkan, M., Andersson, B., Polak, W. G., Laurenzi, A., et al. (2020) · HPB · doi:10.1016/j.hpb.2020.05.012 · Cited by 43
Reuter-Oppermann, M., Müller-Polyzou, R., Wirtz, H., & Georgiadis, A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0233330 · Cited by 35
Impact of the COVID-19 pandemic on patients suffering from musculoskeletal tumours
Thaler, M. R., Khosravi, I., Leithner, A., Papagelopoulos, P. J., & Ruggieri, P. (2020) · International Orthopaedics · doi:10.1007/s00264-020-04636-4 · Cited by 35
Colorectal surgery in Italy during the Covid19 outbreak: a survey from the iCral study group
The Italian Colorectal Anastomotic Leakage (iCral) study group, Caricato, M., Baiocchi, G. L., Crafa, F., Scabini, S., Brisinda, G., Clementi, M., Sica, G. S., Delrio, P., Longo, G., et al. (2020) · Updates in Surgery · doi:10.1007/s13304-020-00760-3 · Cited by 29
Ning, M. S., McAleer, M. F., Jeter, M. D., Minsky, B. D., Ghafar, R. A., Robinson, I. J., Nitsch, P. L., Zaebst, D. J., Todd, S. E., Nguyen, J. L., et al. (2020) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2020.05.037 · Cited by 28
Zuliani, S., Zampiva, I., Tregnago, D., Casali, M., Cavaliere, A., Fumagalli, A., Merler, S., Riva, S. T., Rossi, A., Zacchi, F., et al. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.05.029 · Cited by 28
Achard, V., Aebersold, D. M., Allal, A. S., Andratschke, N. H., Baumert, B. G., Beer, K. T., Betz, M., Breuneval, T., Bodis, S. B., Bari, B. D., et al. (2020) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2020.05.047 · Cited by 27
Pinar, U., Anract, J., Duquesne, I., Dariane, C., Chartier-Kastler, E. J., Cussenot, O., Desgrandchamps, F., Hermieu, J., Irani, J., TAILLE, A. D. L., et al. (2020) · The French Journal of Urology · doi:10.1016/j.purol.2020.05.001 · Cited by 26
Italian survey on managing immune checkpoint inhibitors in oncology during COVID‐19 outbreak
Tagliamento, M., Spagnolo, F., Poggio, F. B., Soldato, D., Conte, B., Ruelle, T., Barisione, E., Maria, A. D., Mastro, L. D., Maïo, M. D., et al. (2020) · European Journal of Clinical Investigation · doi:10.1111/eci.13315 · Cited by 25
Oncology care in a lower middle‐income country during the COVID‐19 pandemic
Trehan, A., Jain, R., & Bansal, D. (2020) · Pediatric Blood & Cancer · doi:10.1002/pbc.28438 · Cited by 25
Iezzi, R., Valente, I., Cina, A., Posa, A., Contegiacomo, A., Alexandre, A. M., D’Argento, F., Lozupone, E., Barone, M., Giubbolini, F., et al. (2020) · European Radiology · doi:10.1007/s00330-020-07041-y · Cited by 25
BRCA testing in a genomic diagnostics referral center during the COVID-19 pandemic
Minucci, A., Scambia, G., Santonocito, C., Concolino, P., & Urbani, A. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05479-3 · Cited by 24
Additional challenges faced by cancer patients in Gaza due to COVID-19
AlWaheidi, S., Sullivan, R., & Davies, E. (2020) · ecancermedicalscience · doi:10.3332/ecancer.2020.ed100 · Cited by 23
Koch, C. A., Lee, G., Liu, Z. A., Liu, F., Fyles, A., Han, K. C.-Z., Barry, A. S., Croke, J. M., Rodin, D. L., Helou, J., et al. (2020) · Advances in Radiation Oncology · doi:10.1016/j.adro.2020.06.002 · Cited by 23
Morrison, D. R., Gentile, C. M., McCammon, S. D., & Buczek, E. P. (2020) · Head & Neck · doi:10.1002/hed.26262 · Cited by 21
Palandri, F., Piciocchi, A., Stefano, V. D., Breccia, M., Finazzi, G., Iurlo, A., Fazi, P., Soddu, S., Martino, B., Siragusa, S. M., et al. (2020) · Leukemia · doi:10.1038/s41375-020-0953-3 · Cited by 16
Continuing our work: transplant surgery and surgical oncology in a tertiary referral COVID-19 center
Berardi, G., Colasanti, M., Sandri, G. B. L., BASSO, C. D., Ferretti, S., Laurenzi, A., Guglielmo, N., Meniconi, R. L., Antonini, M., D’Offizi, G., et al. (2020) · Updates in Surgery · doi:10.1007/s13304-020-00825-3 · Cited by 15
Lee, A. W. M., Xu, Z., Lin, L., Xu, J. H., Jin, Y., Lee, E., Hui, T., & Cheung, J. (2020) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2020.04.031 · Cited by 11
He, C., Li, Y., Huang, X., Hu, S., Yang, Y. J., Liu, Y., Zhao, P., Lin, H., Xu, X., Wang, Y., et al. (2020) · ANZ Journal of Surgery · doi:10.1111/ans.16057 · Cited by 10
Cited by
Cancer treatment and survivorship statistics, 2022
Miller, K. D., Nogueira, L., Devasia, T., Mariotto, A. B., Yabroff, K. R., Jemal, A., Kramer, J., & Siegel, R. L. (2022) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21731 · Cited by 3,597
Force, L. M., Kocarnik, J. M., May, M. L., Bhangdia, K., Crist, A., Penberthy, L., Pritchett, N., Acheson, A., Deitesfeld, L., A, B., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01635-6 · Cited by 494
Global challenges and policy solutions in breast cancer control
Trapani, D., Ginsburg, O., Fadelu, T., Lin, N. U., Hassett, M., Ilbawi, A. M., Anderson, B. O., & Curigliano, G. (2022) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2022.102339 · Cited by 316
Self-citationGaudio, E., Ammar, N., Gunturkun, F., Akkus, C., Brakefield, W., Wakefield, D. V., Pisu, M., Davis, R., Shaban-Nejad, A., & Schwartz, D. L. (2023) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2022.09.073 · Cited by 11
Metadata
- Authors
- Riera, R., Bagattini, Â. M., Pacheco, R. L., Pachito, D. V., Roitberg, F., & Ilbawi, A.
- Venue
- JCO Global Oncology
- Published
- 2021-12
- Volume
- 7
- Issue
- 7
- Pages
- 311-323
- ISSN
- 2687-8941 (ISSN-L)
- OpenAlex
- W3129963120
- Cited by
- 499
- References
- 47
- FWCI
- 16.55
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.